A growing body of evidence indicates that ATP7B is used by malignant cells to detoxify platinum (Pt)-based drugs, thereby promoting tumor resistance to chemotherapy [7,8,9,10,11,12]. The gene discussed is ATP7B; the disease is neoplasm.